Notice
2 May 2025
grants, health, research, patents, drug delivery
💉Correction Notice for Exclusive Patent License on Drug Delivery System
The Department of Health and Human Services corrected a previous notice regarding a prospective grant of an exclusive patent license for a macromolecular drug delivery platform. This announcement pertains specifically to its size-dependent brain and lymphatic distribution characteristics, aiming to facilitate drug delivery innovation.
Learn More
Notice
22 Apr 2025
pharmaceuticals, nih, grant opportunity, biotechnology, patent license, drug delivery, cancer treatment
💉Exclusive Patent License Opportunity for Cancer Treatment Drug Delivery
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents applications listed in the Supplementary Information section of this notice to Sangam Lifesciences, Inc. (Sangam), a company located in Denver, Colorado.
Learn More